Drug delivering technology for endovascular management of infrainguinal peripheral artery disease

Karan Sarode, David A. Spelber, Deepak L. Bhatt, Atif Mohammad, Anand Prasad, Emmanouil S. Brilakis, Subhash Banerjee

Research output: Contribution to journalReview article

32 Scopus citations


Endovascular intervention has become a well-recognized treatment modality for peripheral artery disease; however, mid- and long-term outcomes have been plagued by limited durability. Plain balloon angioplasty and bare-metal stents have historically suffered from high restenosis rates leading to the need for frequent repeat revascularization procedures. The innovation of locally administered, drug-delivering balloons and stents has been a direct result of technological innovations directed toward prevention and treatment of this limitation. Over the last 5 years, numerous clinical trials investigating the use of drug-coated stents and drug-coated balloons indicate a significant improvement in endovascular treatment durability and outcomes. This review provides an up-to-date assessment of the current evidence for the use of drug-coated stents and drug-coated balloons in the treatment of femoropopliteal and infrapopliteal peripheral artery disease. Additionally, it provides an overview of the development of this technology, highlights landmark ongoing and completed clinical trials, examines evidence to support the use of drug-coated technologies in combination with other modalities, and examines promising new technological developments. Last, it summarizes the challenges and safety concerns that have delayed U.S. Food and Drug Administration approval of these devices.

Original languageEnglish (US)
Pages (from-to)827-839
Number of pages13
JournalJACC: Cardiovascular Interventions
Issue number8
StatePublished - Aug 2014



  • drug-coated balloons
  • drug-coated stents
  • peripheral artery disease
  • review

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this